4//SEC Filing
ENDOCYTE INC 4
Accession 0001144204-15-014248
CIK 0001235007operating
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:30 PM ET
Size
8.9 KB
Accession
0001144204-15-014248
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Nguyen Binh
VP of Clinical Affairs
Transactions
- Exercise/Conversion
Common Stock
2015-03-03$3.55/sh+40,000$142,000→ 58,242 total - Sale
Common Stock
2015-03-03$5.79/sh−29,883$172,987→ 28,359 total - Exercise/Conversion
Stock Option (right to buy)
2015-03-03−40,000→ 20,000 totalExercise: $3.55Exp: 2022-02-28→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Shares sold to cover option exercise cost, taxes and fees.
- [F2]Represents the sale of 29,883 shares in multiple transactions, ranging in price from $5.72 to $5.91 per share, resulting in a weighted average sale price of $5.7888. The reporting person will provide, upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- [F3]Shares subject to the option vest annually over a four (4) year period beginning on March 1, 2013.
Documents
Issuer
ENDOCYTE INC
CIK 0001235007
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001235007
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:30 PM ET
- Size
- 8.9 KB